Another option is to use compounds that can form nontoxic complexes with Cu (II), preventing its accumulation in senile plaques and increasing its bioavailability
The strongest evidence for cardiovascular risk reduction exists for semaglutide 2.4mg in patients with established cardiovascular disease (SELECT trial) and liraglutide 1.8mg in type 2 diabetes (LEADER trial), while the obesity-dose of liraglutide (Saxenda 3mg) has demonstrated cardiovascular safety but not superiority
Dihexa: Research dosing in animal models used 0.5 mg/kg
Vitamin B6 (as Pyridoxal 5-Phosphate), Vitamin B12 (as Methylocobalamin), Actiponin Gynostemma Pentaphyllum extract (leaf), Green tea extract (leaf), Other Ingredients: Floli50 (Organic Brown Rice Grain Flower, Organic Brown Rice Sprouted Protein), Hypromellose Vegan Capsule
Part B, Critical Reviews, 9(6), 485- 99